Opinion|Videos|April 28, 2025
FDA-Approved and Pipeline Treatments for Elevated Lp(a) Levels
Experts discuss FDA-approved therapies for high lipoprotein(a) [Lp[a]) levels, their benefits and shortcomings, the frequency of their use in health plans, emerging therapies in the pipeline, and the expected timeline for associated data release.
Advertisement
Video content above is prompted by the following:
- What therapies for high Lp(a) levels are currently approved by the FDA?
- What benefits and shortcomings (eg, cost, time) are associated with this therapy?
- How frequently is this therapy used in the health plans you work with?
- What therapies are in the pipeline?
- When do we expect associated data to be released?
Advertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Special Report: The Oncology Care Model, 10 Years Later
2
FDA Approves Tocilizumab-bavi for CAR-T-Induced CRS, Pediatric COVID-19
3
AI Model Challenges Genomic Classifiers in Early Breast Cancer Risk Stratification: Nancy Lin, MD
4
Weight Loss Drugs Can Improve Outcomes in Patients With Heart Failure and Obesity: Sandra Chaparro, MD
5